Sunil Healthcare Ltd
Incorporated in 1976, Sunil Healthcare Ltd is a manufacturer of Empty Hard Gelatin, HPMC Capsule Shells & Ayurvedic Medicines[1]
- Market Cap ₹ 84.1 Cr.
- Current Price ₹ 82.0
- High / Low ₹ 104 / 60.6
- Stock P/E
- Book Value ₹ 65.4
- Dividend Yield 0.00 %
- ROCE 3.89 %
- ROE -2.10 %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 3.56% over past five years.
- Company has a low return on equity of 1.95% over last 3 years.
- Company has high debtors of 182 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
108.48 | 91.33 | 80.88 | 70.02 | 90.62 | 119.16 | 110.49 | 90.19 | 83.42 | |
93.33 | 77.44 | 69.62 | 76.95 | 85.27 | 101.78 | 94.32 | 85.93 | 73.16 | |
Operating Profit | 15.15 | 13.89 | 11.26 | -6.93 | 5.35 | 17.38 | 16.17 | 4.26 | 10.26 |
OPM % | 13.97% | 15.21% | 13.92% | -9.90% | 5.90% | 14.59% | 14.63% | 4.72% | 12.30% |
1.25 | 2.23 | 0.18 | 14.41 | 5.52 | 1.68 | 4.50 | 5.05 | 1.34 | |
Interest | 4.18 | 5.03 | 6.58 | 6.95 | 5.31 | 3.49 | 4.17 | 5.78 | 6.46 |
Depreciation | 4.33 | 4.78 | 5.74 | 6.13 | 6.11 | 6.31 | 7.01 | 6.09 | 6.35 |
Profit before tax | 7.89 | 6.31 | -0.88 | -5.60 | -0.55 | 9.26 | 9.49 | -2.56 | -1.21 |
Tax % | 36.25% | 28.68% | -20.45% | -11.25% | 16.36% | 30.67% | 29.50% | -30.08% | 16.53% |
5.03 | 4.49 | -0.69 | -4.96 | -0.64 | 6.42 | 6.68 | -1.79 | -1.42 | |
EPS in Rs | 4.91 | 4.38 | -0.67 | -4.84 | -0.62 | 6.26 | 6.51 | -1.75 | -1.38 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 4% |
3 Years: | -11% |
TTM: | -8% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 11% |
3 Years: | % |
TTM: | 12% |
Stock Price CAGR | |
---|---|
10 Years: | 6% |
5 Years: | 30% |
3 Years: | -4% |
1 Year: | -1% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 3% |
3 Years: | 2% |
Last Year: | -2% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 |
Reserves | 32.65 | 37.18 | 36.52 | 34.34 | 33.46 | 39.70 | 45.74 | 57.96 | 56.81 |
44.53 | 60.62 | 55.08 | 49.45 | 49.82 | 34.68 | 36.79 | 66.16 | 68.64 | |
31.41 | 34.16 | 35.88 | 36.19 | 27.03 | 25.06 | 28.01 | 24.13 | 26.24 | |
Total Liabilities | 118.84 | 142.21 | 137.73 | 130.23 | 120.56 | 109.69 | 120.79 | 158.50 | 161.94 |
59.72 | 70.92 | 68.83 | 69.97 | 69.80 | 69.97 | 70.43 | 87.16 | 94.09 | |
CWIP | 0.12 | 0.19 | 2.47 | 0.01 | 0.01 | 1.75 | 0.01 | 5.66 | 0.09 |
Investments | 0.00 | 0.10 | 0.11 | 0.11 | 1.07 | 1.03 | 0.00 | 0.00 | 0.00 |
59.00 | 71.00 | 66.32 | 60.14 | 49.68 | 36.94 | 50.35 | 65.68 | 67.76 | |
Total Assets | 118.84 | 142.21 | 137.73 | 130.23 | 120.56 | 109.69 | 120.79 | 158.50 | 161.94 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
10.79 | 5.48 | 14.73 | 4.31 | 16.99 | 22.51 | 7.47 | -15.40 | 11.52 | |
-12.85 | -17.18 | -2.80 | -2.52 | -11.36 | -4.24 | -3.40 | -10.11 | -7.70 | |
2.23 | 11.02 | -11.63 | -1.56 | -6.42 | -18.56 | -3.75 | 25.00 | -3.87 | |
Net Cash Flow | 0.17 | -0.67 | 0.30 | 0.23 | -0.79 | -0.29 | 0.32 | -0.51 | -0.05 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
Debtor Days | 129.57 | 192.39 | 177.08 | 122.81 | 94.37 | 57.86 | 93.85 | 164.27 | 182.19 |
Inventory Days | 76.09 | 101.63 | 213.19 | 322.80 | 117.09 | 83.25 | 105.15 | 110.57 | 175.58 |
Days Payable | 138.91 | 180.29 | 294.23 | 292.81 | 109.16 | 65.01 | 114.04 | 47.85 | 88.69 |
Cash Conversion Cycle | 66.75 | 113.73 | 96.04 | 152.81 | 102.30 | 76.09 | 84.96 | 226.99 | 269.09 |
Working Capital Days | 81.09 | 137.76 | 125.82 | 105.51 | 84.06 | 46.50 | 84.80 | 192.11 | 212.91 |
ROCE % | 11.60% | 5.43% | 1.65% | 5.12% | 14.25% | 15.30% | 2.98% | 3.89% |
Documents
Announcements
-
Board Meeting Intimation for Intimation Of The Board Meeting Scheduled To Be Held On 30.07.2025, Pursuant To Regulation 29 Read With Regulation 33 Of The SEBI (LODR) Regulations, 2015.
18 Jul - Board meeting on July 30 to approve Q1 FY26 unaudited results; trading window closed July 1-Aug 1.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
8 Jul - Certificate confirming dematerialization compliance for Q1 FY 2025-26 under SEBI regulations.
- Closure of Trading Window 27 Jun
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
31 May - Copy of newspaper clipping regarding publication of audited financial results for the quarter/year ended 31.03.2025
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
30 May - Annual Secretarial Compliance Certificate filed for FY 2024-25 by Sunil Healthcare.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Nov 2018TranscriptNotesPPT
-
Sep 2018TranscriptNotesPPT
-
May 2018TranscriptNotesPPT
-
May 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Dec 2017TranscriptNotesPPT
-
Aug 2017TranscriptNotesPPT
-
May 2017TranscriptNotesPPT
-
Feb 2017TranscriptNotesPPT
-
Nov 2016TranscriptNotesPPT
-
Aug 2016TranscriptNotesPPT
-
May 2016TranscriptNotesPPT
-
Mar 2016TranscriptNotesPPT
Business Overview:[1]
Company is the second-largest manufacturer of Empty Hard Shell Gelatin Capsules in India which its sells under the brand name Sunloc. Company does production of double lock, triple lock, multiple groove capsules of EHGC & some proportion of vegan HPMC (Hydroxy Propyl Methyl Cellulose) along with liner, circular, two color printing & 360degree printing being offered